Magnetic nanoparticles comprising a core formed from noble metals
View Patent ↗The invention relates to nanoparticles of noble metals, having a controlled microstructure which leads to the appearance of ferromagnetic behaviour in said nanoparticles, thereby enabling the use of very small magnets (<5 nm) in a range in which standard ferromagnetic metals behave as superparamagnetic entitles (disappearance of hysteresis cycle). The inventive nanoparticles can be used, for example, to reduce the dimensions in magnetic recordings, as well as in biomedicine as tools for biomolecule recognition, nuclear magnetic resonance imaging, drug-release control or hypothermia treatments.
1. Magnetic nanoparticles of noble metals having a size of less than 5 nm, the nanoparticles comprising:
a) a core formed from a noble metal and
b) an anisotropic layer formed from compounds containing at least one metal-sulphur covalent bond wherein the nanoparticles display ferromagnetic behavior at room temperature and a hysteresis cycle, and further wherein the nanoparticles are formed from a non-ferromagnetic precursor noble metal.
2. Magnetic nanoparticles of noble metals according to claim 1 , wherein the noble metal for the core is Au, Pd, Pt, or Ag.
3. Magnetic nanoparticles of noble metals according to claim 1 , wherein the size of the nanoparticles lies between 1.0 and 2.0 nm.
4. Magnetic nanoparticles of noble metals according to claim 1 , wherein when the core is formed from Au, the anisotropic layer contains Au—S compounds and Au—S—R compounds in proportions between 1/1000 and 1000/1 (Au—S/Au—S—R), wherein R is an aliphatic chain.
5. Magnetic nanoparticles of noble metals according to claim 4 , wherein R is an aliphatic chain or an aliphatic chain in turn joined to other molecules, R being able to contain a marker, a fluorescent group or a radioactive isotope.
6. Magnetic nanoparticles of noble metals according to claim 5 , wherein the other molecules are proteins or other biomolecules.
7. Magnetic nanoparticles of noble metals according to claim 1 , wherein when the core is formed from Pd, the anisotropic layer contains Pd—S compounds and Pd—S—R compounds in proportions between 1/1000 and 1000/1 (Pd—S/Pd—S—R), wherein R is an aliphatic chain.
8. Magnetic nanoparticles of noble metals according to claim 7 , wherein R is an aliphatic chain or an aliphatic chain in turn joined to other molecules, R being able to contain a marker, a fluorescent group or a radioactive isotope.
9. Magnetic nanoparticles of noble metals according to claim 8 , wherein the other molecules are proteins or other biomolecules.
10. Magnetic nanoparticles of noble metals according to claim 1 , wherein the size of the nanoparticles lies between 1.2 and 1.4 nm.
11. Biosensor which comprises the magnetic nanoparticles of claim 1 therein.
12. Magneto-optical device comprising the magnetic nanoparticles of claim 1 therein.
13. Coding device which comprises the magnetic nanoparticles of claim 1 therein.
14. A system which comprises a population of one or more of the nanoparticles according to claim 1 .
15. A system according to claim 14 which comprises a plurality of nanoparticles containing different functional groups.
16. Process for preparation of magnetic nanoparticles according to claim 1 , comprising the reaction of the non-ferromagnetic precursor noble metal with a stoichiometric excess of a thiol derivative of general formula HS—R, wherein R is an aliphatic chain, and in the presence of a reducing agent, under conditions such that the anisotropic layer contains metal-sulfur covalent bonds.
17. Process for preparation of magnetic nanoparticles according to claim 16 , wherein when the non-ferromagnetic precursor noble metal is gold the precursor is prepared by means of reaction of tetrachloroauric acid with a stoichiometric excess of any quaternary ammonium salt.
18. Process for preparation of magnetic nanoparticles according to claim 16 , wherein when the non-ferromagnetic precursor noble metal is palladium the precursor is prepared by means of reaction of a palladium salt comprising nitrate, sulphate or chloride, with a stoichiometric excess of a quaternary ammonium salt.
19. Method for increasing the density of information in a magnetic recording which comprises forming an ordered distribution of the magnetic nanoparticles of claim 1 on a support of the magnetic recording.
20. Method for controlled release of drugs which comprises employing the nanoparticles of claim 1 as tracers in a device for such release.
21. Method for hyperthermia treatment which comprises employing the nanoparticles of claim 1 in a region to be heated.
22. Method for improving the imaging in nuclear magnetic resonance which comprises employing the nanoparticles of claim 1 as a contrast medium.
23. Method for magnetic printing which comprises employing the magnetic nanoparticles of claim 1 as a powder in an ink-forming dispersion.